ACE2 and COVID-19: Therefore, IL-6 and IL-6 AMP are biomarkers of hyperactivation of inflammatory machinery exacerbated by ACE2 blocking and viral infection, which represent key cytokines in deciphering cytokine-related syndrome and disease progression of COVID-19 [41,45,46].